468 related articles for article (PubMed ID: 16144485)
1. Photodynamic therapy of Walker tumors by multiple laser irradiation.
Calin MA; Gruia MI; Herascu N; Coman T
Photomed Laser Surg; 2005 Aug; 23(4):405-9. PubMed ID: 16144485
[TBL] [Abstract][Full Text] [Related]
2. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
Calin MA; Gruia Ml; Herascu N; Coman T
J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
[TBL] [Abstract][Full Text] [Related]
3. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
4. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation.
Forster B; Klein A; Szeimies RM; Maisch T
Exp Dermatol; 2010 Sep; 19(9):806-12. PubMed ID: 20636354
[TBL] [Abstract][Full Text] [Related]
5. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
6. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy using 5-aminolevulinic acid triggered DNA damage of adenocarcinoma breast cancer and hepatocellular carcinoma cell lines.
Abo-Zeid MAM; Abo-Elfadl MT; Mostafa SM
Photodiagnosis Photodyn Ther; 2018 Mar; 21():351-356. PubMed ID: 29355735
[TBL] [Abstract][Full Text] [Related]
8. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 5-aminolevulinic acid and its hexylester mediated photodynamic action on human hepatoma cells.
Ren QG; Wu SM; Peng Q; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):650-4. PubMed ID: 12198571
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-aminolevulinic acid-mediated photodynamic therapy on antibiotic-resistant staphylococcal biofilm: an in vitro study.
Li X; Guo H; Tian Q; Zheng G; Hu Y; Fu Y; Tan H
J Surg Res; 2013 Oct; 184(2):1013-21. PubMed ID: 23622723
[TBL] [Abstract][Full Text] [Related]
11. Targeting of sebaceous glands by δ-aminolevulinic acid-based photodynamic therapy: An in vivo study.
Kosaka S; Miyoshi N; Akilov OE; Hasan T; Kawana S
Lasers Surg Med; 2011 Jul; 43(5):376-81. PubMed ID: 21674542
[TBL] [Abstract][Full Text] [Related]
12. Influence of administration methods on the accumulation of ALA-induced Pp-IX in mouse tongue tumors.
Ogasawara T; Miyoshi N; Sano K; Kitagawa Y; Yamada T; Ogawa T; Miyauchi K; Kinoshita H
Oral Dis; 2006 Jul; 12(4):415-9. PubMed ID: 16792728
[TBL] [Abstract][Full Text] [Related]
13. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin.
Van der Veen N; De Bruijn HS; Star WM
Int J Cancer; 1997 Jul; 72(1):110-8. PubMed ID: 9212231
[TBL] [Abstract][Full Text] [Related]
14. In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid.
Betz CS; Lai JP; Xiang W; Janda P; Heinrich P; Stepp H; Baumgartner R; Leunig A
Photochem Photobiol Sci; 2002 May; 1(5):315-9. PubMed ID: 12653468
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
16. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status.
Marcus SL; Sobel RS; Golub AL; Carroll RL; Lundahl S; Shulman DG
J Clin Laser Med Surg; 1996 Apr; 14(2):59-66. PubMed ID: 9484077
[TBL] [Abstract][Full Text] [Related]
18. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
[TBL] [Abstract][Full Text] [Related]
19. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Peng Q; Warloe T; Berg K; Moan J; Kongshaug M; Giercksky KE; Nesland JM
Cancer; 1997 Jun; 79(12):2282-308. PubMed ID: 9191516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]